547 research outputs found
Corrigendum to “Delta SARS-CoV-2 variant is entirely substituted by the omicron variant during the fifth COVID-19 wave in Attica region” [Sci. Total Environ., 856(Pt 1) (2023)/159062] (Science of the Total Environment (2023) 856(P1), (S0048969722061617), (10.1016/j.scitotenv.2022.159062))
No full textThe authors state that the printed version of the above article missed the contribution of an author, which was that the third author had contributed to the writing of the original draft in addition to methodology. The correct and final version follows. CRediT authorship contribution statement Aikaterini Galani: Methodology, Validation, Writing – original draft. Athina Markou: Supervision, Writing – review & editing, Project administration. Lampros Dimitrakopoulos: Methodology, Writing – original draft. Aikaterini Kontou: Validation. Marios Kostakis: Validation. Vasileios Kapes: Methodology. Marios A. Diamantopoulos: Formal analysis, Software. Panagiotis G. Adamopoulos: Formal analysis. Margaritis Avgeris: Formal analysis, Writing– review & editing. Evi Lianidou: Writing – review & editing. Andreas Scorilas: Formal analysis. Dimitrios Paraskevis: Writing – review & editing. Sotirios Tsiodras: Writing – review & editing. Meletios-Athanasios Dimopoulos: Funding acquisition, Writing – review & editing. Nikolaos Thomaidis: Conceptualization, Project administration, Visualization, Resources. © 2022 Elsevier B.V
Efstathios Kastritis, Athanasios Anagnostopoulos, Maria Roussou, Dimitra Gika, Charis Matsouka, Despina Barmparousi
No full textEfstathios Kastritis, Athanasios Anagnostopoulos, Maria Roussou, Dimitra Gika, Charis Matsouka, Despina Barmparousi
No full textMeletios A. Dimopoulos, Giampaolo Merlini, Veronique Leblond, Athanasios Anagnostopoulos, Raymond Alexanian
No full textMeletios A. Dimopoulos, Giampaolo Merlini, Veronique Leblond, Athanasios Anagnostopoulos, Raymond Alexanian
No full text
Approach to Contemporary Risk Assessment, Prevention and Management of Thrombotic Complications in Multiple Myeloma
No full textMultiple myeloma (MM) is associated with an increased risk of thrombotic complications, which remains substantial despite the implementation of thromboprophylaxis. The procoagulant state that characterizes the disease is multifactorial, and a greater understanding of the underlying pathophysiology is required to inform appropriate thrombosis prevention. Currently, there is a shift towards using direct oral anticoagulants (DOACs) in this setting; head-to-head comparisons in the context of controlled clinical trials between class agents are still missing. MM-specific VTE risk assessment scores have been developed to optimize management and minimize the associated mortality/morbidity. Their clinical utility remains to be evaluated. The value of adding biomarkers to clinical scores to optimize their performance and increase their discriminatory power is also under assessment
- …
